Compliance
AAHP Research on Safety of Homeopathy
By Mark Land, MS, RAC-US, AAHP President Each year one issue of the AAHP newsletter focuses on research. The March 2023 issue delved into basic and clinical research, as well…
Read MoreEffective Strategies for Homeopathic Product Packaging: Balancing Regulatory Requirements and Brand Appeal
The homeopathic industry has seen significant growth and increased visibility, bringing with it increased scrutiny from regulatory bodies like the U.S. Food and Drug Administration (FDA). To thrive in this…
Read MoreConsumer-Friendly Drug Product Labels
By Mark Land, MS, RAC-US, AAHP President In 2016 I wrote an article on labeling homeopathic drug products for self-medication. At that time, I reported that there were more than…
Read MoreDisclaimers in Character-Limited Media
By Mark Land, M.S., RAC-US, AAHP President The Federal Trade Commission (FTC) issued an enforcement policy statement on marketing claims for OTC homeopathic drugs on November 15, 2016.1 As a…
Read MoreContemporary Advertising
By Mark Land, MS, RAC-US, AAHP President It is not an exaggeration to say that advertising has evolved delivery, scale, and targeting exponentially with the emergence of digitally enabled content.…
Read MoreThe Importance of Purified Water Systems in the Pharmaceutical Industry
By Mark Land, MS, RAC-US, AAHP President My first experience with a water treatment system was a double deionization, pre- and post-filtration technique. There was no storage or recirculation. It…
Read MoreCompliance Efforts — Where to Put One’s Priorities?
by Eric Foxman, Pharm. (Ret.) FDA Compliance Being in compliance and being prepared for an inspection are time and resource- consuming activities. Yet both are necessary and required of every…
Read MorePresent Foresight to Protect the Future
By Mark Land, MS, RAC-US, AAHP President AAHP planned this issue of the newsletter to focus on stewardship several months ago as part of our annual editorial calendar. I knew…
Read MoreQuality/Regulatory Support of New Product Introductions
By Mark Land, MS, RAC-US, AAHP President The introduction of a new product at retail is a team effort. Meeting technical information requirements to support a new product introduction is…
Read MoreFDA Issues FY23 Drug Safety Priorities Report
In February 2024, FDA’s Center for Drug Evaluation and Research (CDER) published its ninth yearly report describing key safety programs and activities, and illustrating the depth and versatility of drug…
Read More